4//SEC Filing
Schwartz Aharon 4
Accession 0001104659-23-001495
CIK 0001006281other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:08 PM ET
Size
5.3 KB
Accession
0001104659-23-001495
Insider Transaction Report
Form 4
Schwartz Aharon
Director
Transactions
- Purchase
Common Stock
2023-01-03$1.42/sh+110,000$155,815→ 174,000 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $1.430 to $1.405 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001625184
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:08 PM ET
- Size
- 5.3 KB